Andrew Flower

TL;DR: This work is presented at the I1 World Congress for Integrative Medicine & Health 2017 a global forum for exploring the future of comprehensive patient care in Washington, DC.

TL;DR: The effectiveness and safety of CHM in alleviating endometriosis-related pain and infertility is reviewed and it is suggested it may have comparable benefits to gestrinone but with fewer side effects than danazol.

TL;DR: Evidence from seven small studies suggested that CHM as an independent intervention or in conjunction with antibiotics may be beneficial for treating recurrent UTIs during the acute phase of infection and may reduce the recurrent UTI incidence for at least six months post-treatment.

TL;DR: It is possible that oral CHM used in conjunction with chemotherapy may improve QoL in NSCLC and this needs to be examined further with more rigorous methodology.

TL;DR: The practice of CHM is introduced and the key considerations that need to be addressed whilst researching this traditional medical system are introduced to encourage a thoughtful and meticulous process of investigation that will clarify the contribution that CHM can make to the authors' future healthcare.